In 2023, global digital health funding halved for the second year in a row with just $13.2 billion raised in 1,397 deals, according to CB Insights. Deal size was around $4 million and the median digital health deal size trended upward. However, there were only three $100 million-plus deals in the fourth quarter of last year and the digital health unicorns are becoming even less common.
The digital health market has also seen consolidation and partnerships to further integrate into hospitals and health systems. Yahoo Finance compiled the 12 most valuable U.S.-based digital health companies based on current market caps.
1. CVS Health: $97 billion
2. DexCom: $44.5 billion
3. IQVIA: $42.7 billion
4. Veeva Systems: $34.6 billion
5. Simulations Plus: $8.2 billion
6. Doximity: $5.3 billion
7. Health Catalyst: $5.3 billion
8. NeuroPace: $4.1 billion
9. DocGo: $3.6 billion
10. Movano: $3.4 billion
11. Amwell: $3.3 billion
12. 23andMe: $3.2 billion
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
